By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis today announced the licensing of certain patents to Novartis covering certain uses of homologous recombination.

The deal grants the Swiss-based pharmaceutical firm patents for the family WO 90/11354. The technology belongs to the Pasteur Institute and Cellectis owns exclusive rights to them.

The technology allows researchers to introduce new characteristics into genomes.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.